News About: Pharm. Industry
Korea to create 200-billion won fund
The Ministry of Health and Welfare will attract investment from the private sector to set up a 200-billion won R&D fund by 2014 to finance local firms' large-scale research and development (R&D) projects, as the Natio...
MasterControl opens Korean branch
The U.S. based MasterControl Inc., a global provider of quality management software (QMS) solutions for the life science and manufacturing industries, said Tuesday it has launched its Korean branch, MasterControl Kore...
Hanmi, Sanofi-Aventis Korea announce partnership
Hanmi Pharmaceutical said yesterday that it has established a marketing and distribution partnership with Sanofi-Aventis Korea.
Under the deal, Sanofi-Aventis Korea will be in charge of selling Hanmi’s combination...
Celgene’s cancer pill to increase global sales
Celgene Corp. is increasing global sales for its best-selling cancer pill Revlimid (lenalidomide) on new data that may convince doctors to choose the drug as a first option.
Revlimid generated $970 million in sales...
Pharmaceutical firms reluctant to hire able salespersons
Local drug firms are now making efforts to foster their own salespersons and refrain from scouting able salespersons associated with their competitors excessively.
As their profits continue to fall in the domestic ...
CJ to discontinue selling Hituben
CJ Cheil Jedang will not continue to maintain its strategic alliance with Takeda Korea over Hituben, a cold remedy.
CJ and Takeda Korea agreed not to renew the contract which will expire at the end of December.
...
Small drug makers scramble to survive
A small drug firm has recently decided to supply its drugs through wholesalers, discarding its policy to make a direct transaction with pharmacies.
Market sources said that the company has endeavored to lower costs...
Pharmaceutical firms' operating profit dips 7.2% in nine months
A pharmaceutical information provider said Monday that Korean pharmaceutical companies saw their nine-month operating profits drop 7.2 percent, compared to 10.6 percent from a year earlier due mainly to shrunken marke...
KPMA to get tough on predatory pricing in hospital bidding market
Predatory pricing, commonly referred to as “dumping in the domestic hospital bidding market has recently produced negative side effects that require the attention of policymakers as well as the National Assembly.
T...
Competition stiff for DPP-4 inhibitors
Multinational pharmaceutical companies are stepping up their marketing in the dipeptidyl peptidase-4 (DPP-4) inhibitors in Korea, which is forecast to become more competitive than ever early next year, according to in...
